Status: current, Defined. Date: 30-Nov 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4242541000168114 | ravulizumab (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4242551000168111 | ravulizumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ravulizumab | Is a | medicinal product | true | Inferred relationship | Some | ||
| ravulizumab | has intended active ingredient | ravulizumab | true | Inferred relationship | Some | 1455823011 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| ravulizumab 300 mg/30 mL injection, vial | Is a | True | ravulizumab | Inferred relationship | Some | |
| ravulizumab 300 mg/3 mL injection, vial | Is a | True | ravulizumab | Inferred relationship | Some | |
| ravulizumab 1.1 g/11 mL injection, vial | Is a | True | ravulizumab | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR